Skip to Content

Vanguard CIV H3N2

This page contains information on Vanguard CIV H3N2 for veterinary use.
The information provided typically includes the following:
  • Vanguard CIV H3N2 Indications
  • Warnings and cautions for Vanguard CIV H3N2
  • Direction and dosage information for Vanguard CIV H3N2

Vanguard CIV H3N2

This treatment applies to the following species:
Manufacturer: Zoetis

Canine Influenza Vaccine, H3N2, Killed Virus

For use by, or under the supervision of, a veterinarian.

For vaccination of healthy dogs as an aid in the control of disease associated with canine influenza (H3N2) virus infection.

Directions For Use

Vaccination of healthy dogs is recommended. Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs 8 weeks of age and older should receive 2 doses administered 3 weeks apart. Annual revaccination with a single dose is recommended.

Precautions

Store at 2°-7°C (35°-45°F). Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Contains gentamicin as preservative.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).

For veterinary use only

U.S. Veterinary License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

25 1-dose (1-mL) vials of vaccine

50015101

CPN: 3690518.1

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone:   269-359-4414
Customer Service:   888-963-8471
Website:   www.zoetis.com
Every effort has been made to ensure the accuracy of the Vanguard CIV H3N2 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2017 North American Compendiums. Updated: 2017-11-28

Hide